NextCure NXTC
$ 0.93
-4.11%
Quarterly report 2024-Q3
added 11-07-2024
NextCure Balance Sheet 2011-2024 | NXTC
Annual Balance Sheet NextCure
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-6.48 M | -19.5 M | - | -29.3 M | -29.1 M | -135 M | -7.57 M | - | - | - | - | - | - |
Long Term Debt |
5.95 M | 6.6 M | - | 1.81 M | 3.33 M | 73 K | 460 K | - | - | - | - | - | - |
Long Term Debt Current |
656 K | 518 K | - | 1.67 M | 1.67 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 2.6 M | - | 184 M | 40.8 M | - | - | - | - | - | - |
Total Current Liabilities |
6.88 M | 9.13 M | 6.61 M | 10.3 M | 15 M | - | - | - | - | - | - | - | - |
Total Liabilities |
13.6 M | 16.6 M | 9 M | 12.9 M | 34.7 M | 195 M | 43.9 M | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | 4.99 M | - | - | - | - | - | - | - |
Retained Earnings |
-324 M | -262 M | -187 M | -118 M | -81 M | -47.3 M | -24.5 M | - | - | - | - | - | - |
Total Assets |
128 M | 184 M | 242 M | 307 M | 356 M | 148 M | 19.5 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
13.1 M | 26.6 M | 12.3 M | 32.8 M | 34.1 M | 136 M | - | - | - | - | - | - | - |
Book Value |
114 M | 168 M | 233 M | 294 M | 321 M | -46.9 M | -24.4 M | - | - | - | - | - | - |
Total Shareholders Equity |
114 M | 168 M | 233 M | 294 M | 321 M | -46.9 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet NextCure
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
5.39 M | 5.59 M | 5.77 M | 5.95 M | 6.12 M | 6.29 M | 6.45 M | 6.6 M | - | - | - | - | - | 972 K | 1.39 M | 1.81 M | 1.81 M | 1.81 M | 1.81 M | 3.33 M | 3.33 M | 3.33 M | 3.33 M | 73 K | 73 K | 73 K | 73 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
14.8 M | 17.1 M | 16.1 M | 13.6 M | 13.5 M | 15 M | 13.6 M | 16.6 M | 8.37 M | - | 8.81 M | 9 M | 9.6 M | 11.8 M | 11.8 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 34.7 M | 34.7 M | 34.7 M | 34.7 M | 32.3 M | 32.3 M | 32.3 M | 32.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-369 M | -357 M | -342 M | -324 M | -310 M | -296 M | -278 M | -262 M | -244 M | - | -208 M | -187 M | -170 M | -152 M | -134 M | -118 M | -118 M | -118 M | -118 M | -81 M | -81 M | -81 M | -81 M | -47.3 M | -47.3 M | -47.3 M | -47.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
90.3 M | 103 M | 115 M | 128 M | 140 M | 153 M | 168 M | 184 M | 190 M | - | 223 M | 242 M | 258 M | 275 M | 291 M | 307 M | 307 M | 307 M | 307 M | 356 M | 356 M | 356 M | 356 M | 148 M | 148 M | 148 M | 148 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
27.7 M | 20.8 M | 18.4 M | 13.1 M | 19.5 M | 22 M | 30 M | 26.6 M | 31.1 M | 28.2 M | 10.7 M | 12.3 M | 36.7 M | 34.9 M | 36.5 M | 32.8 M | 32.8 M | 32.8 M | 32.8 M | 34.1 M | 34.1 M | 34.1 M | 34.1 M | 135 M | 135 M | 135 M | 135 M | 9.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
75.6 M | 85.4 M | 99 M | 114 M | 126 M | 138 M | 154 M | 168 M | 182 M | - | 214 M | 233 M | 248 M | 264 M | 279 M | 294 M | 294 M | 294 M | 294 M | 321 M | 321 M | 321 M | 321 M | 115 M | 115 M | 115 M | 115 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
75.6 M | 85.4 M | 99 M | 114 M | 126 M | 138 M | 154 M | 168 M | 182 M | 198 M | 214 M | 233 M | 248 M | 264 M | 279 M | 294 M | 294 M | 294 M | 294 M | 321 M | 321 M | 321 M | 321 M | -46.9 M | -46.9 M | -46.9 M | -46.9 M | -24.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency